Literature DB >> 19421363

Hypereosinophilic syndrome with characteristic left ventricular thrombus demonstrated by contrast echocardiography.

J C Adams1, J P Dal-Bianco, G Kumar, M J Callahan.   

Abstract

Hypereosinophilic syndrome (HES) is a rare condition characterised by idiopathic eosinophilia with organ system involvement. The condition is far more common in males, with a typical onset in the third to sixth decade. Cardiac damage may result in the formation of a characteristic apical thrombus readily visualised on two-dimensional echocardiography. Cardiac involvement portends a less favourable prognosis as it can be complicated by acute embolic events and progressive development of restrictive cardiomyopathy, valvular dysfunction, and heart failure. In this case report, we describe a middle-aged gentleman with HES and characteristic apical thrombus identified on contrast echocardiography. Although the use of contrast agents for assessment of left ventricular thrombus is documented in the literature,1 this case illustrates the application of contrast echocardiography in the evaluation of eosinophilia. (Neth Heart J 2009;17:169-70.).

Entities:  

Keywords:  contrast echocardiography; hypereosinophilic syndrome; left ventricular thrombus

Year:  2009        PMID: 19421363      PMCID: PMC2669247          DOI: 10.1007/BF03086240

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  8 in total

Review 1.  The clinical applications of contrast echocardiography.

Authors:  Robert Olszewski; Jon Timperley; Cezary Szmigielski; Szmigielski Cezary; Mark Monaghan; Petros Nihoyannopoulos; Petros Nihoyannopoulis; Roxy Senior; Harald Becher
Journal:  Eur J Echocardiogr       Date:  2007-06

Review 2.  The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.

Authors:  M J Chusid; D C Dale; B C West; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1975-01       Impact factor: 1.889

Review 3.  The idiopathic hypereosinophilic syndrome.

Authors:  P F Weller; G J Bubley
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

4.  A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Authors:  Jan Cools; Daniel J DeAngelo; Jason Gotlib; Elizabeth H Stover; Robert D Legare; Jorges Cortes; Jeffrey Kutok; Jennifer Clark; Ilene Galinsky; James D Griffin; Nicholas C P Cross; Ayalew Tefferi; James Malone; Rafeul Alam; Stanley L Schrier; Janet Schmid; Michal Rose; Peter Vandenberghe; Gregor Verhoef; Marc Boogaerts; Iwona Wlodarska; Hagop Kantarjian; Peter Marynen; Steven E Coutre; Richard Stone; D Gary Gilliland
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

Review 5.  Atypical myeloproliferative disorders: diagnosis and management.

Authors:  Ayalew Tefferi; Michelle A Elliott; Animesh Pardanani
Journal:  Mayo Clin Proc       Date:  2006-04       Impact factor: 7.616

6.  Hypereosinophilic syndrome with characteristic left ventricular thrombus demonstrated by contrast echocardiography.

Authors:  J C Adams; J P Dal-Bianco; G Kumar; M J Callahan
Journal:  Neth Heart J       Date:  2009-04       Impact factor: 2.380

7.  FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia.

Authors:  Animesh Pardanani; Stephanie R Brockman; Sarah F Paternoster; Heather C Flynn; Rhett P Ketterling; Terra L Lasho; Ching-Liang Ho; Chin-Yang Li; Gordon W Dewald; Ayalew Tefferi
Journal:  Blood       Date:  2004-07-29       Impact factor: 22.113

8.  Hypereosinophilic syndrome: case presentation and update.

Authors:  Kristin M Leiferman; Gerald J Gleich
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

  8 in total
  5 in total

1.  Is this still just sarcoidosis, or should we a-DRESS a different diagnosis?

Authors:  Sophie Rolls; Catherine Hyams; Michael Sheaff; Terence C O'Shaughnessy
Journal:  BMJ Case Rep       Date:  2015-06-29

2.  Hypereosinophilic syndrome with characteristic left ventricular thrombus demonstrated by contrast echocardiography.

Authors:  J C Adams; J P Dal-Bianco; G Kumar; M J Callahan
Journal:  Neth Heart J       Date:  2009-04       Impact factor: 2.380

3.  Prognostic Value of Eosinophil to Leukocyte Ratio in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Takao Konishi; Naohiro Funayama; Tadashi Yamamoto; Toru Morita; Daisuke Hotta; Hiroshi Nishihara; Shinya Tanaka
Journal:  J Atheroscler Thromb       Date:  2016-12-01       Impact factor: 4.928

4.  Hypereosinophilic Syndrome Leading to Severe Right-Sided Heart Failure in a Patient with Ebstein's Anomaly.

Authors:  Joas John Kyabonaki; Bjarne Linde Nørgaard; Søren Høyer; Niels Holmark Andersen
Journal:  Case Rep Cardiol       Date:  2013-05-23

5.  Transient left ventricular clot in COVID-19-related myocarditis is associated with hypereosinophilic syndrome: a case report.

Authors:  Naghmeh Ziaie; Davood Mansouri; Parviz Amri Maleh; Mohammad Mostafa Ansari Ramandi; Roghayeh Pourkia; Kayvan Latifi
Journal:  Int J Cardiovasc Imaging       Date:  2021-06-23       Impact factor: 2.357

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.